Lemaitre Vascular Inc 63 Second Avenueburlington Ma 01803 Pma Numbern16837 Supplement Numbers029 Date Received12 30 2022 Decision Date01 25 2023 Product Code Lxa Advisory Committee Cardiovascular Supplement Type30 Day Notice Supplement Reason Process Change Manufacturer Sterilizer Packager Supplier Expedited Review Granted No

FDA Filings

This page includes the latest FDA filings for Lemaitre Vascular Inc 63 Second Avenueburlington Ma 01803 Pma Numbern16837 Supplement Numbers029 Date Received12 30 2022 Decision Date01 25 2023 Product Code Lxa Advisory Committee Cardiovascular Supplement Type30 Day Notice Supplement Reason Process Change Manufacturer Sterilizer Packager Supplier Expedited Review Granted No. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

FDA Filings

Device Company	Device	Date
PMA N16837S029 LeMaitre Vascular, Inc.63 Second Avenueburlington, MA 01803 PMA NumberN16837 Supplement NumberS029 Date Received12/30/2022 Decision Date01/25/2023 Product Code LXA  Advisory Committee Cardiovascular Supplement Type30-day Notice Supplement Reason Process Change - Manufacturer/sterilizer/packager/supplier Expedited Review Granted? No	Artegraft Collagen Vascular Graft	2023-01-25